BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26840084)

  • 1. Irsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice.
    Onuma W; Tomono S; Miyamoto S; Fujii G; Hamoya T; Fujimoto K; Miyoshi N; Fukai F; Wakabayashi K; Mutoh M
    Oncotarget; 2016 Feb; 7(8):8640-52. PubMed ID: 26840084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
    Zhang X; Tajima K; Kageyama K; Kyoi T
    World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
    Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
    J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irsogladine maleate counters the interleukin-1 beta-induced suppression in gap-junctional intercellular communication but does not affect the interleukin-1 beta-induced zonula occludens protein-1 levels in human gingival epithelial cells.
    Fujita T; Ashikaga A; Shiba H; Kajiya M; Kishimoto A; Hirata R; Tsunekuni N; Hirono C; Kawaguchi H; Shiba Y; Kurihara H
    J Periodontal Res; 2008 Feb; 43(1):96-102. PubMed ID: 18230110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
    Kyoi T; Noda K; Oka M; Ukai Y
    Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production.
    Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O
    Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
    Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
    Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
    Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
    Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
    Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
    PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
    Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
    Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice.
    Noma N; Fujii G; Miyamoto S; Komiya M; Nakanishi R; Shimura M; Tanuma SI; Mutoh M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irsogladine prevents monochloramine-induced gastric mucosal lesions by improving the decrease in mucosal blood flow due to the disturbance of nitric oxide synthesis in rats.
    Kyoi T; Oka M; Noda K; Ukai Y
    J Pharmacol Sci; 2003 Nov; 93(3):314-20. PubMed ID: 14646249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice.
    Barone M; Notarnicola M; Caruso MG; Scavo MP; Viggiani MT; Tutino V; Polimeno L; Pesetti B; Di Leo A; Francavilla A
    Carcinogenesis; 2014 Jul; 35(7):1613-9. PubMed ID: 24632492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cyclic AMP content of rat gastric mucosa induced by ulcerogenic stimuli--in relation to the antiulcer activity of irsogladine maleate.
    Ueda F; Watanabe M; Hirata Y; Kyoi T; Kimura K
    Jpn J Pharmacol; 1991 Apr; 55(4):493-9. PubMed ID: 1653374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.
    Janakiram NB; Mohammed A; Bryant T; Lightfoot S; Collin PD; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2015 Apr; 8(4):327-37. PubMed ID: 25657017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice.
    Kuno T; Hatano Y; Tomita H; Hara A; Hirose Y; Hirata A; Mori H; Terasaki M; Masuda S; Tanaka T
    Carcinogenesis; 2013 Feb; 34(2):361-9. PubMed ID: 23125223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.
    Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M
    Carcinogenesis; 2003 Jul; 24(7):1219-24. PubMed ID: 12807720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats.
    Tatsumi Y; Tanino M; Kodama T; Kashima K; Katsura M; Okuma S
    Jpn J Pharmacol; 1998 Aug; 77(4):293-9. PubMed ID: 9749930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.
    Wang X; Kingsley PJ; Marnett LJ; Eling TE
    Cancer Prev Res (Phila); 2011 Jan; 4(1):150-60. PubMed ID: 21205743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.